Spectrum Pharmaceuticals
SPPI
$1.08
Share price
-2.27%
Change (1 day)
29.52%
Change (1 year)
Categories
Revenue for Spectrum Pharmaceuticals (SPPI)
Revenue in 2023 (TTM): $25.72 M
According to Spectrum Pharmaceuticals 's latest financial reports the company's current revenue (TTM) is $25.72 M. In 2022 the company made a revenue of $10.11 M an increase over the years 2021 revenue that were of N/A.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Spectrum Pharmaceuticals from 2001 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $25.72 M | 154.39% |
| 2022 | $10.11 M | INF% |
| 2021 | N/A | NAN% |
| 2020 | N/A | NAN% |
| 2019 | N/A | -100% |
| 2018 | $0.10 B | -14.83% |
| 2017 | $0.12 B | -12.34% |
| 2016 | $0.14 B | -9.91% |
| 2015 | $0.16 B | -12.99% |
| 2014 | $0.18 B | 19.87% |
| 2013 | $0.15 B | -21.55% |
| 2012 | $0.19 B | 2.95% |
| 2011 | $0.19 B | 160.36% |
| 2010 | $74.11 M | 94.91% |
| 2009 | $38.02 M | |
| 2007 | $7.67 M | |
| 2002 | $2.37 M | 5667.83% |
| 2001 | $0.04 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $96.26 B | 374,042.02% | 🇺🇸 USA |
 Novartis NVS | $52.22 B | 202,869.41% | 🇨🇭 Switzerland |
 Pfizer PFE | $92.95 B | 361,173.27% | 🇺🇸 USA |
 Abbott Laboratories ABT | $41.50 B | 161,216.02% | 🇺🇸 USA |
 Biogen BIIB | $10.10 B | 39,173.19% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $45.84 B | 178,095.81% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $34.70 B | 134,771.27% | 🇬🇧 UK |
 Seagen
SGEN | $2.05 B | 7,889.70% | 🇺🇸 USA |
 Curis CRIS | $10.4 M | -59.57% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $14.92 B | 57,912.36% | 🇮🇱 Israel |